Keiichi Fukuda

Company: Heartseed Inc
Job title: Chief Executive Officer
Seminars:
New Era of Heart Failure Treatment: Regenerative Cell Therapy Using Ventricular Specific Purified Cardiomyocytes 9:00 am
Scalable method to eliminate undifferentiated iPSCs by difference of metabolism between iPSCs and cardiomyocytes Clinical data from FIH study of purified cardiomyocyte spheroids Platform technology to develop high quality iPSC-derived productRead more
day: Conference Day Two